Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and dactinomycin

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with dactinomycin in 2 studies

Compound Research Comparison

Studies
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)
Trials
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)
Recent Studies (post-2010)
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)
Studies
(dactinomycin)
Trials
(dactinomycin)
Recent Studies (post-2010) (dactinomycin)
380019,045355969

Protein Interaction Comparison

ProteinTaxonomy3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin (IC50)dactinomycin (IC50)
RAD51Homo sapiens (human)32.1
Growth factor receptor-bound protein 2Homo sapiens (human)5
Discoidin domain-containing receptor 2Homo sapiens (human)9
Growth factor receptor-bound protein 2 Mus musculus (house mouse)5

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, FM; Mullins, TD; Newman, RA; Rose, KM; Wassermann, K1
Acton, EM; Andersson, BS; Bakic, M; Mullins, TD; Newman, RA; Silberman, LE; Wassermann, K; Zwelling, LA1

Other Studies

2 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and dactinomycin

ArticleYear
Selective inhibition of human ribosomal gene transcription by the morpholinyl anthracyclines cyanomorpholinyl- and morpholinyldoxorubicin.
    Cancer research, 1988, Jul-15, Volume: 48, Issue:14

    Topics: Dactinomycin; Doxorubicin; Fluorescent Antibody Technique; HeLa Cells; Humans; Microscopy, Electron; Ribosomes; RNA Polymerase I; Transcription, Genetic

1988
Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
    Cancer research, 1986, Volume: 46, Issue:8

    Topics: Antibiotics, Antineoplastic; Cell Nucleolus; Cell Survival; Cells, Cultured; Dactinomycin; DNA, Neoplasm; Doxorubicin; Humans; Leukemia; RNA, Neoplasm; Structure-Activity Relationship

1986